Toluene

Toluene

SCHEMBL28755877

CCCOC(=O)NO.Cc1ccccc1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.51
▸ ALDH1A1 P00352 6/20 0.49
▸ POLB P06746 1/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ GAA P10253 2/20 0.46
▸ MAPK1 P28482 2/20 0.44
▸ HPGD P15428 3/20 0.44
▸ MMP8 P22894 3/20 0.44
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ GLA P06280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylbenzene SCHEMBL27814992 0.85 LMNA (0.54) LMNAALDH1A1SMN1; SMN2GAAMAPK1
SCHEMBL851200 0.81 — —
Acetic Acid Propyl Ester SCHEMBL1780772 0.80 LMNA (0.56) LMNAALDH1A1SMN1; SMN2GAAHPGD
Butane SCHEMBL28032310 0.79 KDM4E (0.48) ALDH1A1SMN1; SMN2MAPK1HPGDMEN1
Acetic Acid Propyl Ester SCHEMBL27540158 0.79 LMNA (0.55) LMNAALDH1A1SMN1; SMN2GAAHPGD
Toluene SCHEMBL11845704 0.76 LMNA (0.51) LMNAALDH1A1SMN1; SMN2GAAHPGD
SCHEMBL3229905 0.75 HPGD (0.67) LMNAALDH1A1SMN1; SMN2GAAMAPK1
SCHEMBL4922122 0.75 LMNA (0.50) LMNAALDH1A1POLBSMN1; SMN2GAA
Toluene SCHEMBL27508716 0.75 THRB (0.57) LMNAALDH1A1SMN1; SMN2GAAHPGD
SCHEMBL10192026 0.74 SMN1; SMN2 (0.69) LMNAALDH1A1POLBSMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100475819-C Pseudopolymorphic forms of a HIV protease inhibitor TIBOTEC PHARM LTD (IE) 2009-04-08 — — CN claimed
CN-1898248-B Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate TIBOTEC PHARM LTD 2011-08-17 — — CN disclosed
CN-102131815-A Process for the preparation of (3R,3AS,6AR) -hexahydrofuro [2,3-B ] furan-3-yl (1S,2R) -3- [ [ (4-aminophenyl) sulfonyl ] (isobutyl) amino ] -1-benzyl-2-hydroxypropyl carbamate TIBOTEC PHARM LTD 2011-07-20 — — CN disclosed
CN-100475819-C Pseudopolymorphic forms of a HIV protease inhibitor TIBOTEC PHARM LTD (IE) 2009-04-08 — — CN disclosed
CN-1898248-A Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate TIBOTEC PHARM LTD (IE) 2007-01-17 — — CN disclosed
CN-1668623-A Pseudopolymorphic forms of a HIV protease inhibitor TIBOTEC PHARM LTD (IE) 2005-09-14 — — CN disclosed
Send feedback